A Randomised Cross-over Study With Two 1-piece Urostomy Bags.
NCT00765388 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2014-03-11
Summary
Background Urostomy is a surgical procedure that detours or diverts urine away form a diseased or defective bladder. The bladder can be removed and the urine is passed out of the body through an opening (stoma) in the stomach. People with urostomy will not be able to start and stop urine coming out through the stoma, so a urostomy bag will be fitted to collect the urine as it comes out.
A urostomy bag consists of an adhesive, which is attached to the skin around the stoma and a bag connected to the adhesive to collect the urine.
It is very important the standard is high on these products; otherwise the user (urostomy-patient) will experience lots of problems with the skin around the stoma.
Conditions
- Urostomy
Interventions
- DEVICE
-
SenSura Uro
The test product is a CE-marked non-sterile one-piece urostomy multi-chamber bag with the SenSura adhesive.
- DEVICE
-
Hollister
The comparator product is CE-marked and non-sterile and produced for urostomy operated. It is a flat one-piece urostomy product, Hollister Moderma Flex Urostomy beige, Cut-to-Fit Bag, flat adhesive.
Sponsors & Collaborators
-
Coloplast A/S
lead INDUSTRY
Principal Investigators
-
Carol Katte, Stoma Nurse · Ashford and St. Peters Hospital
-
Maureen Bridgland, Stoma Nurse · Royal Sussex County Hospital
-
Caroline Rudoni, Stoma Nurse · St. Georges Hospital
-
Theresa Bowles, Stoma Nurse · Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
-
Michael Lynch, Surgeon · Colchester General Hospital
-
Sharon Fillingham, Nurse · UCLH
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-10-31
- Primary Completion
- 2009-05-31
- Completion
- 2009-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury
NCT03503513 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Incidence of Urinary Tract Infection After Urodynamic Investigation
NCT01297647 ·Status: COMPLETED ·Phase: NA
-
URACYST® For the Treatment of GAG Deficient Interstitial Cystitis
NCT00150488 ·Status: COMPLETED ·Phase: NA
-
Bladder Morphology Using 2 Different Catheter Designs
NCT03108079 ·Status: UNKNOWN ·Phase: NA
-
Implementation Study With Decision Support Based on Data
NCT04408976 ·Status: COMPLETED
-
A Novel Urinary Access System for Universal Transcatheter Cystoscopy at The Time of Hysterectomy
NCT03503175 ·Status: UNKNOWN ·Phase: NA
-
Bladder Shaper Test
NCT04017000 ·Status: COMPLETED ·Phase: NA
-
Comparing the Usability of an Electronic Bladder Diary and a Paper Bladder Diary
NCT03249987 ·Status: COMPLETED ·Phase: NA
-
Alternative Prophylaxis in Female Recurrent Urinary Tract Infections
NCT04095572 ·Status: RECRUITING ·Phase: PHASE4
-
NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis
NCT06128213 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study
NCT05652374 ·Status: RECRUITING ·Phase: PHASE4
-
The Use of the UroShield Device in Patients With Indwelling Urinary Catheters
NCT00446732 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Ureteral Stents Length and Location on Related Symptom
NCT05069376 ·Status: COMPLETED ·Phase: NA
-
Potentiated Aminoglycosides in Postoperative Urinary Tract Infection Prophylaxis
NCT05761405 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
NCT00919113 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.
NCT01813565 ·Status: TERMINATED ·Phase: NA
-
Multifaceted Treatment of Catheter-related Urinary Tract Infection
NCT00732238 ·Status: COMPLETED ·Phase: PHASE2
-
Cystoscopy and Cystodistension; Therapeutic and Aetiological Aspect in Overactive Bladder
NCT01971437 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort Study on Tolerability & Safety of Uro-Tainer® Polihexanide 0.02%
NCT02157415 ·Status: TERMINATED ·Phase: NA
-
Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)
NCT04173013 ·Status: NO_LONGER_AVAILABLE
-
Open Prospective Study on Reduction of Bacteriuria Following Bladder Irrigation With Chlorhexidine
NCT01782404 ·Status: COMPLETED ·Phase: NA
-
Participant Satisfaction and Quality of Life With Catheter Washouts in Adults Living With Long-Term Catheters and Currently Using Uro-Tainer® Polihexanide 0.02%
NCT06920953 ·Status: NOT_YET_RECRUITING
-
Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections
NCT03931408 ·Status: COMPLETED ·Phase: PHASE2
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
NCT03522961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Silver-Coated vs Standard Catheter for UTI Prevention
NCT05408533 ·Status: COMPLETED ·Phase: NA